NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 26 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,414,674 | -3.5% | 1,511,000 | -6.2% | 0.00% | – |
| Q2 2023 | $1,466,010 | -0.8% | 1,611,000 | +0.2% | 0.00% | – |
| Q1 2023 | $1,478,000 | +98171.3% | 1,608,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,504 | -97.9% | 1,608,000 | +2073.0% | 0.00% | – |
| Q3 2022 | $70,000 | +40.0% | 74,000 | +42.3% | 0.00% | – |
| Q2 2022 | $50,000 | -95.2% | 52,000 | -94.6% | 0.00% | – |
| Q1 2022 | $1,034,000 | -47.8% | 961,000 | -31.9% | 0.00% | – |
| Q3 2021 | $1,979,000 | -42.9% | 1,411,000 | -29.4% | 0.00% | – |
| Q2 2021 | $3,467,000 | +62.9% | 2,000,000 | +42.5% | 0.00% | – |
| Q1 2021 | $2,128,000 | +106300.0% | 1,404,000 | +140300.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 1,000 | -50.0% | 0.00% | – |
| Q2 2020 | $3,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 10,000,000 | $15,644,000 | 3.40% |
| Perceptive Advisors | 9,000,000 | $141,822,000 | 2.07% |
| DeepCurrents Investment Group LLC | 14,430,000 | $22,483,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,784,000 | 0.46% |
| Polar Asset Management Partners Inc. | 17,500,000 | $27,302,000 | 0.37% |
| ZAZOVE ASSOCIATES LLC | 1,320,000 | $2,063,000 | 0.27% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,000,000 | $24,947,000 | 0.22% |
| Context Capital Management, LLC | 500,000 | $768,000 | 0.17% |
| Context Partners Fund, L.P. | 500,000 | $768,000 | 0.17% |
| PFM Health Sciences, LP | 2,000,000 | $3,151,000 | 0.15% |